The eligibility under the Nairobi Protocol of the Lumia system from China
No revocation or modification of this ruling appears in the Customs Bulletin issues read here (Nov 6, 2024 through Nov 18, 2026), where CBP publishes most such actions. That is not confirmation that the ruling is still in effect. Confirm its status with CBP before relying on it (ruling on CBP CROSS).
Ruling text
In your letter dated April 1, 2025, on behalf of your client, Lumia Health, you requested a ruling to determine the eligibility of the Lumia system under the Nairobi Protocol. The item under consideration is described as the Lumia system, which is a system designed to fit in the cymba concha of the outer ear and provides biometric data to the user.
The device utilizes infrared light to non-invasively assess blood flow through a branch of the posterior auricular artery located in the ear, enabling it to track blood flow to the head. By shining light on this artery, Lumia captures a blood flow waveform, which is used to measure the heart rate and blood flow. The device consists of three primary physical subsystems. The earpiece measures biometric data and transmits it to the docking station.
It is primarily made of printed circuit board assemblies (PCBAs), molded plastic housings, and an injection molded outer silicone jacket. The docking station relays the earpiece data to the cloud where additional data analysis is done and transmits to the mobile app. The docking station has a base PCBA, LED PCBA, and an injection molded plastic housing. The carrying case protects the earpiece when not in use and is made of an injection-molded plastic housing.
According to your letter, the Lumia device is intended exclusively for individuals with chronic blood flow disorders and conditions, and the purchasing process incorporates a qualifier survey to ensure that only eligible buyers can proceed. Those who do not meet the criteria are blocked from purchase, ensuring that credit cards are not charged.
You additionally state that unlike standard wearables that measure heart rate through green light, capturing blood flow signals in shallow capillaries at the wrist or finger, Lumia specifically targets arterial signals at the head, providing users, particularly those with chronic blood flow disorders, a better understanding of how their lifestyle choices impact their symptoms.
In your request, you ask if the Lumia system is “eligible for importation under the Nairobi Protocol SPI.” The United States, one of the signatories, has implemented part of the United Nations Nairobi Protocol, currently, via a provision for a secondary classification for articles for the handicapped in Harmonized Tariff Schedule of the United States (HTSUS) 9817.00.92 through 9817.00.96 and US Note 4 to Subpart 17 to Chapter 98.
From the information provided, you state the Lumia system obtains biometric data insights for individuals suffering from chronic conditions such as postural orthostatic tachycardia syndrome (POTS), orthostatic hypotension, orthostatic intolerance, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), and long COVID. You further claim that the device’s location makes obtaining the information unique because it is specifically obtaining the information from the head region.
The issue is whether the Lumia system is “specially designed or adapted” for the use or benefit of handicapped persons, which is required by the superior text in subheading 9817.00.96, HTSUS.
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (N347289).